throbber
THE JOURNAL OF BIOLOGICAL CHEMISTRY
`© 1985 by The American Society of Biological Chemists, Inc.
`
`Vol. 260, No.6, Issue of March 25, pp. 3330-3336, 1985
`Printed in U.S.A.
`
`Branchpoint for Heme Alkylation and Metabolite Formation in the
`Oxidation of Arylacetylenes by Cytochrome P-450*
`
`(Received for publication, August 13, 1984)
`
`Paul R. Ortiz de Montellano and Elizabeth A. Komives
`From the Department of Pharmaceutical Chemistry, School of Pharmacy, and Liver Center, University of California,
`San Francisco, California 94143
`
`Phenylaeetylene and biphenylaeetylene are oxidized
`by cytochrome P-450 to the corresponding arylacetic
`acids. The acetylenic hydrogen shifts to the adjacent
`carbon and one atom of molecular oxygen is incorpo(cid:173)
`rated into the carboxylic acid group in these transfor(cid:173)
`mations, which are subject to a large kinetic isotope
`effect when the acetylenic hydrogen is replaced by
`deuterium. The same products and isotope effects are
`observed when the two arylacetylenes are oxidized by
`m-chloroperbenzoic acid rather than by the enzyme.
`In contrast, the inactivation of cytochrome P-450 that
`occurs during the oxidation of phenylacetylene is in(cid:173)
`sensitive to deuterium substitution. The partition ratio
`between metabolite formation and enzyme inactivation
`consequently changes from 26 to 15 in going from
`phenylacetylene to the deuterated analogue. Metabo(cid:173)
`lite formation therefore diverges from heme alkylation
`very early in the catalytic process.
`
`The epoxidation of olefins by cytochrome P-450 could
`involve simultaneous formation of bonds between the acti·
`vated oxygen and the two carbons of the 1r-bond, or formation
`of the two bonds in discrete steps separated by an ionic or
`radical intermediate. Retention of the olefin stereochemistry
`in the epoxides favors a concerted epoxidation mechanism
`(1-4), but the fact that the prosthetic heme of cytochrome P-
`450 is alkylated during the oxidation of terminal olefins favors
`a nonconcerted mechanism. Heme1 alkylation, which also
`occurs with retention of the olefin stereochemistry (4), is
`observed when the activated oxygen is transferred to the
`internal carbon of the 1r-bonds (5-9). Additional support for
`a nonconcerted mechanism is provided by the reports that
`1,2-chlorine migration precedes rather than follows epoxide
`formation from halogenated olefins (10, 11), that aldehydes
`and ketones are formed as trace metabolites from certain
`olefins in a process that does not involve the epoxide (11, 12),
`and that the oxidation of styrene is subject to a secondary
`isotope effect when deuterium is located on the internal but
`not the terminal carbon of the 1r-bond (13).
`The cytochrome P-450-catalyzed oxidation of a carbon(cid:173)
`carbon triple bond, a reaction formally related to olefin epox(cid:173)
`idation, has only been unambiguously demonstrated in the
`
`metabolism of biphenylacetylenes (14-19) but is implied by
`the excretion of phenylacetic acid when animals are treated
`with phenylacetylene (20) and by rearrangements observed in
`the metabolism of 17-ethynyl sterols (9). The catalytic oxi(cid:173)
`dation of biphenylacetylene yields biphenylacetic acid in a
`reaction subject to a kinetic isotope effect of 1.4 when the
`acetylenic hydrogen is replaced by deuterium (19). The pos(cid:173)
`sibility that oxygen is inserted into the acetylenic carbon(cid:173)
`hydrogen bond, suggested by the isotope effect, is ruled out
`by quantitative shift of the acetylenic hydrogen to the vicinal
`carbon during the oxidation (17-19) and by the observation
`of a similar intramolecular hydrogen shift in the chemical
`oxidation of biphenylacetylene (17, 18). The enzymatic oxi(cid:173)
`dation of acetylenes, like that of olefins, thus involves reaction
`of the activated oxygen with the 1r-bond. In agreement with
`this, the turnover of acetylenes by cytochrome P-450 results
`in alkylation of the prosthetic heme group (21-23) and the
`formation of heme adducts similar to those obtained with
`terminal olefins (7, 24, 25). We describe here a mechanistic
`investigation of the oxidation of 1r-bonds by cytochrome P-
`450 that exploits the hydrogen shift associated with triple
`bond oxidation as an experimental probe.
`
`MATERIALS AND METHODS2
`
`RESULTS
`Incorporation of Oxygen into the Biphenylacetylene Metab(cid:173)
`olite-Biphenylacetylene was incubated with hepatic micro(cid:173)
`somes from phenobarbital-pretreated rats under an 180 2 at(cid:173)
`mosphere, and the resulting biphenylacetic acid was isolated
`and methylated with diazomethane. Mass spectrometric anal(cid:173)
`ysis (Fig. 1) of the esterified metabolite established that
`approximately 75% of one oxygen in the carboxylic acid
`moiety derived from labeled molecular oxygen. This fractional
`incorporation of label points to catalytic incorporation of one
`atom of molecular oxygen because some dilution of the label
`by oxygen not removed in the purging operations is unavoid(cid:173)
`able. The second oxygen in the carboxyl group, by implication,
`derives from the medium.
`Kinetic Isotope Effect in the Metabolism of Biphenylacety(cid:173)
`lene-The kinetic isotope effect for the oxidation of biphen(cid:173)
`ylacetylene was remeasured to confirm the value reported
`earlier (kH/kD = 1.42) (19). Labeled and unlabeled biphen-
`
`*This research was supported by Grant GM 25515 from the
`National Institutes of Health. Support for facilities used in the
`investigation was provided by Liver Center Core Facility Grant P-30
`AM 26743 and by Grant AM 30297. The costs of publication of this
`article were defrayed in part by the payment of page charges. This
`article must therefore be hereby marked "advertisement" in accord(cid:173)
`ance with 18 U.S.C. Section 1734 solely to indicate this fact.
`1 Heme is used in this paper for iron protoporphyrin IX regardless
`of the oxidation state of the iron or the porphyrin.
`
`2 Portions of this paper (including "Materials and Methods," Ta(cid:173)
`bles 1 and 2, and Figs. 1, 3, 4, and 6) are presented in miniprint at
`the end of this paper. Miniprint is easily read with the aid of a
`standard magnifying glass. Full size photocopies are available from
`the Journal of Biological Chemistry, 9650 Rockville Pike, Bethesda,
`MD 20814. Request Document No. 84M-2538, cite the authors, and
`include a check or money order for $4.00 per set of photocopies. Full
`size photocopies are also included in the microfilm edition of the
`Journal that is available from Waverly Press.
`
`3330
`
`Boehringer Ex. 2017
`Mylan v. Boehringer Ingelheim
`IPR2016-01564
`Page 1
`
`

`
`Mechanism of 1r-Bond Oxidation
`
`3331
`
`~~~----~--------------------------,
`
`ylacetylene were incubated with hepatic microsomes from
`phenobarbital-induced rats and aliquots were taken from the
`incubation mixtures at 10-min intervals. Biphenylacetylene
`and biphenylacetic acid were extracted into methylene chlo(cid:173)
`ride, and their concentrations were determined spectroscopi(cid:173)
`cally. This spectroscopic assay is feasible because the absor(cid:173)
`bance maximum of biphenylacetylene is at 273 nm whereas
`that of biphenylacetic acid is at 254 nm, although direct
`spectroscopic analysis of the incubation mixture is not pos(cid:173)
`sible because an interfering chromophore is present in the
`assay mixture that is eliminated in the extraction procedure.
`Metabolite formation is limited to the first 10 min of the
`incubation because the same amount of metabolite is present
`at 30 as at 10 min. The isotope effect calculated from the data
`is kH/ko = 1.38 (Table 1), a value within experimental error
`of that obtained earlier by a gas chromatographic assay (19).
`Isotope Effects on the Destruction of Cytochrome P-450 by
`Arylacetylenes-Biphenylacetylene causes NADPH-
`and
`time-dependent loss of cytochrome P-450 when incubated
`with hepatic microsomes from phenobarbital-pretreated rats
`(Table 2). The enzyme loss determined by spectroscopic quan(cid:173)
`titation of the ferrous-carbon monoxide complex, however,
`does not exceed 4-5% of the total microsomal enzyme. This
`loss occurs within the first 10 min and is not increased if the
`incubation is prolonged a further 20 min. Essentially identical
`results are obtained when the incubations are carried out with
`(1-2H)biphenylacetylene (Table 2). The quantitative reliabil(cid:173)
`ity of these values, however, is compromised by their small
`magnitude and by the fact that they reflect a 4% correction
`for the enzyme lost in the absence of substrates.
`The completion of both metabolite formation and enzyme
`inactivation within the same 10 min period suggests that one
`isozyme, representing no more than 4-5% of the cytochrome
`P-450 in microsomes from phenobarbital-induced rats, is in(cid:173)
`volved in both processes. This result, unexpected in view of
`the report that phenobarbital and 3-methylcholanthrene
`stimulate biphenylacetylene metabolism (14), led us to inves(cid:173)
`tigate whether the cytochrome P-450 loss could be amplified
`by pretreatment with clofibrate, an inducer of cytochrome P-
`450 enzymes involved in fatty acid hydroxylation (27, 28), or
`Arochlor 1254, an inducer of multiple isozymes (29, 30).
`However, microsomal enzyme loss from Arochlor 1254-treated
`rats is the same as that from phenobarbital-treated rats while
`enzyme loss from clofibrate-treated rats is negligible (Table
`2). These results suggest that biphenylacetylene is a specific
`substrate for a minor, phenobarbital-inducible, isozyme.
`Phenylacetylene was found earlier to cause time- and
`NADPH dependent loss of cytochrome P-450 when incubated
`with hepatic microsomes from phenobarbital-pretreated rats
`(22). Losses of 18, 25, and 27% were observed after 10, 20,
`and 30 min of incubation with 10 mM phenylacetylene. A
`hepatic pigment with the absorption spectrum of anN-alkyl(cid:173)
`protoporphyrin IX derivative was furthermore isolated from
`the livers of rats injected with phenylacetylene (22). The
`larger amplitude of the cytochrome P-450 loss and the evi(cid:173)
`dence that phenylacetylene alkylates the prosthetic heme of
`cytochrome P-450 led us to use it as an alternative probe of
`the oxidative mechanism. The rates of inactivation of cyto(cid:173)
`chrome P-450 by phenylacetylene and [1-2H]phenylacetylene
`appear, within experimental error, to be identical (Fig. 2).
`The Metabolism of Phenylacetylene-No information is
`available on the metabolism of phenylacetylene except for the
`report that phenylacetic acid is excreted by rabbits injected
`with phenylacetylene (20). Phenylacetylene therefore was in(cid:173)
`cubated with hepatic microsomes from phenobarbital-pre(cid:173)
`treated rats and the metabolites were isolated by extraction
`
`liOOtJ
`i :l: 40
`
`'f
`a.
`

`
`0
`
`10
`5
`T•me(min)
`
`15
`
`FIG. 2. The metabolism of phenylacetylene to phenylacetate
`(0) and [l-2H}phenylacetylene to [2-'aH)phenylacetate (D) by
`hepatic microsomes from phenobarbital-induced rats. The loss
`of cytochrome P-450 caused by each of these two compounds (symbols
`as in the main panel) as a semilog function of time, assuming that
`the 30% maximum loss of cytochrome P-450 observed in long term
`incubations is equal to 100% of the vulnerable enzyme, is given in
`the inset.
`
`into diethyl ether. The diethyl ether fraction, after esterifi(cid:173)
`cation with diazomethane, was analyzed by gas chromatog(cid:173)
`raphy. The only quantitatively significant (>5%) metabolite
`detected in the extracts is the methyl ester of phenylacetic
`acid (Fig. 3). A specific search was made for acetophenone,
`but none was detected. The metabolite was identified as
`phenylacetic acid by direct gas chromatographic and mass
`spectrometric comparison with an authentic sample (not
`shown).
`The pattern of metabolites obtained with [1-2H]phenyla(cid:173)
`cetylene is the same as that obtained with the unlabeled
`substrate, but the molecular ion of the methyl phenylacetate
`metabolite is 1 mass unit higher (Fig. 4). The peak for the
`fragment obtained by decarboxylation of the molecular ion
`retains the difference of 1 mass unit. It is thus evident that
`the acetylenic hydrogen of phenylacetylene, like that of bi(cid:173)
`phenylacetylene, shifts quantitatively to the vicinal carbon
`on oxidation of the triple bond.
`Kinetic Isotope Effect in the Metabolism of Phenylacety(cid:173)
`lene-The formation of phenylacetic acid from phenylacety(cid:173)
`lene and [1-2H]phenylacetylene in incubations with hepatic
`microsomes from phenobarbital-pretreated rats was quanti(cid:173)
`tated as a function of time by gas chromatographic analysis
`(Fig. 2). Deuterium substitution significantly retards enzy(cid:173)
`matic oxidation of the triple bond and gives rise to a kinetic
`isotope effect kH/kn
`1.80 (Table 1).
`The isotope effect for phenylacetylene metabolism was
`independently measured by incubating a 1:1 mixture of phen(cid:173)
`ylacetylene and [1-2H]phenylacetylene with hepatic micro(cid:173)
`somes and quantitating the ratio of the deuterated to undeu(cid:173)
`teratedphenylacetic acid metabolites by gas chromatography(cid:173)
`mass spectrometry. The kinetic isotope effect obtained by this
`internal competition method (kH/kn
`1.60) (Table 1) con(cid:173)
`firms that the oxidation ofphenylacetylene by cytochrome P-
`450 is subject to a major isotope effect.
`Isotope Effects on the Chemical Oxidation of Arylacety(cid:173)
`lenes-The oxidation of biphenylacetylene by m-chloroper(cid:173)
`benzoic acid in methylene chloride with a trace of methanol
`yields methyl 2-biphenylacetate as the only detectable prod(cid:173)
`uct. The ratio of the rates of reaction with biphenylacetylene
`and [1-2H)biphenylacetylene reflects an isotope effect kH/kn
`1.38 (Table 1). Attempts to study the oxidation of phen-
`
`Boehringer Ex. 2017
`Mylan v. Boehringer Ingelheim
`IPR2016-01564
`Page 2
`
`

`
`3332
`Mechanism of 1r-Bond Oxidation
`1.5.-------------------.
`
`N
`
`I
`N
`
`N
`I
`N
`
`~ 0.3
`
`2
`Time (hr)
`FIG. 5. The oxidation of phenylacetylene to phenylacetate
`(0) and [l-2H)phenylacetylene to [2- 2H)phenylacetate (0) by
`m-chloroperbenzoic acid in anhydrous benzene.
`
`4
`
`5
`
`ylacetylene under the same conditions, however, were unsuc(cid:173)
`cessful due to the low reactivity of this substrate. The oxida(cid:173)
`tion of phenylacetylene was therefore examined in anhydrous
`benzene in the absence of proton sources as described in an
`earlier study (31). A kinetic isotope effect kH/ko = 1.73 is
`obtained from the rates of product formation from phenyla(cid:173)
`cetylene and [1-2H]phenylacetylene under these conditions
`(Fig. 5). Addition of methanol to the reaction mixture altered
`the kinetics and attenuated the isotope effect, but these
`changes were not investigated.
`
`DISCUSSION
`The oxidation of [1-2H]phenylacetylene by both cyto(cid:173)
`chrome P-450 and m-chloroperbenzoic acid yields phenyla(cid:173)
`cetic acid with the acetylenic deuterium atom shifted to the
`benzylic carbon. The oxidation of phenylacetylene thus pro(cid:173)
`ceeds with a 1,2-hydrogen shift identical to that shown to
`occur previously in the oxidation of biphenylacetylene (17
`18). The oxidation of carbon-carbon triple bonds with con~
`comitant shift of the acetylenic hydrogen thus appears to be
`a general, if frequently only minor, metabolic process.3 The
`analogy between the enzymatic and chemical processes is
`strengthened by the incorporation of a labeled oxygen atom
`into the carboxylic acid function when biphenylacetylene is
`incubated under 180 2 because this labeling pattern is that
`expected if biphenylacetylene is oxidized to biphenylketene
`which then reacts with a molecule of water. The chemical
`oxidation of acetylenes is believed to proceed through such a
`ketene mechanism (32).
`The oxygen atom is bound to the terminal carbon in the
`arylacetylene metabolites but to the internal carbon in the
`heme adducts (Scheme 1) (7, 24, 25). The terminal carbon in
`the heme adducts is the site to which the protoporphyrin IX
`prosthetic group is bound. The reaction regiochemistry ob(cid:173)
`served in the metabolites is favored by rate-determining ox(cid:173)
`ygen addition to the 1r-bond because any electron deficiency
`that develops in the transition state can be stabilized by
`conjugation with the phenyl ring. The absence of acetophe(cid:173)
`none among the metabolites in the chemical and enzymatic
`reactions supports the view that metabolites stem from deliv(cid:173)
`ery of the oxygen to the terminal carbon. The fact that
`
`3 Enzymatic oxidation of the triple bond in an alkyl acetylene ( 4-
`phenylbutyne) with concomitant 1,2-shift of the hydrogen has been
`demonstrated (P. R. Ortiz de Montellano, C. R. Wheeler, and E.
`Komives, unpublished results).
`
`Fe
`.11
`b/~
`lb
`
`Ar-c-cH•
`
`/N
`N
`
`N
`
`/
`N
`0~~·
`
`N
`
`N/
`
`Fe
`
`N
`
`N/
`
`a
`
`Ar....._ +
`C=C=o•
`•H/
`
`l~
`
`H •H
`OH
`)/...__
`Ar c/
`
`·~
`
`Ar
`
`SCHEME 1. The two consequences of cytochrome P-450-catalyzed
`arylacetylene oxidation. The square of nitrogens stands for protopor(cid:173)
`phyrin IX. The stars denote labeled atoms.
`
`hydrogen migration is coupled to metabolite formation but
`not heme alkylation makes the observation of differential
`isotope effects highly informative. Olefins are not suitable for
`such studies because the regiochemistry of oxygen addition
`which is masked in the epoxide products, can only be extracted
`by kinetic studies of secondary isotope effects. The isotope
`effects measured here for conversion of biphenylacetylene to
`biphenylacetic acid (kH/ko = 1.38) and phenylacetylene to 2-
`phenylacetic acid (kH/ko = 1.80), on the other hand, establish
`th~t enz~matic triple bond oxidation is subject to quite large
`J?nmary Isotop~ effects. T~e observed isotope effects approx(cid:173)
`Imate the maximum possible values for transition states in
`which the hydrogen moves in a sidewise rather than linear
`fashion (see Scheme 3) between the donor and acceptor atoms.
`Theoretical calculations suggest that the maximum isotope
`effect, barring tunneling effects, for a linear transition state
`(C-H-C angle= 180°) is approximately kH/kn = 7.9 whereas
`the corresponding values for angles of 1200, 90°, and 600 are
`3.0, 1.7, and 0.9, respectively (33). Experimental isotope ef(cid:173)
`fects for reactions known to involve bent transition states
`conform to these theoretical predictions (e.g. pinacol rear(cid:173)
`rangement (kH/ko = 2.7-3.3) (34), amine oxide pyrolysis (kH/
`ko = 2.7-3.2) (35), insertion of carbenes into C-H bonds (kH/
`ko = 0.9-2.5) (36, 37), 1,2-shift of a hydrogen to a vicinal
`carbene center (kH/ko = 1.7) (38), and epoxide ring cleavage
`concerted with 1,2-shift of a hydrogen (kH/ko = 1.59) (39)).
`The secondary isotope effects on a reaction in which the
`carbons undergo sp to sp2 rehybridization are, on the contrary,
`expected to be inverse and of much smaller magnitude (40).
`The primary isotope effects observed in this study are there(cid:173)
`fore, if anything, slightly larger than the cited values if allow(cid:173)
`ance is made for secondary isotope effects. Proportionately
`large intrinsic isotope effects have been demonstrated for
`~ytochrom~ P-450-catalyzed carbon hydroxylations by exper(cid:173)
`Iments which measure the competition between deuterated
`and undeuterated sites in the same molecule (43, 44), but the
`present V max isotope effects are among the largest (relative to
`the theoretical maximum) so far observed for cytochrome P-
`450.
`Oxidation of the biphenylacetylene triple bond with m(cid:173)
`chloroperbenzoic acid parallels the biological reaction in all
`respects including, as shown here, the magnitude of the kinetic
`isotope effect associated with replacement of the acetylenic
`hydrogen by deuterium. The isotope effect for the chemical
`oxidation of biphenylacetylene (kH/ko = 1.82) is larger than
`
`Boehringer Ex. 2017
`Mylan v. Boehringer Ingelheim
`IPR2016-01564
`Page 3
`
`

`
`Mechanism of 1r-Bond Oxidation
`
`3333
`
`1.38) but is com(cid:173)
`that for the enzymatic oxidation (kH/ko
`parable to that for the enzymatic (kH/ko 1.80) and chemical
`(kHfko = 1.73) oxidations of phenylacetylene. The isotope
`effect in the chemical reaction requires that oxygen transfer
`from the peracid to the triple bond occur in concert with
`hydrogen migration. The alternative explanation, formation
`of a quasi-stable oxirene intermediate that decomposes to the
`ketene product in a second, rate-limiting, step, is incompatible
`with the failure to detect (much less isolate) oxirene inter(cid:173)
`mediates even in frozen matrixes at cryogenic temperatures
`(32, 43, 44). The isotope effect data essentially rule out the
`formation of oxirenes in the perbenzoic acid reaction and
`consequently resolve the long standing question of whether
`oxirenes are formed in the chemical oxidation (32). The data
`substantiate the theoretically predicted asymmetry of the
`transition state for the oxidation of acetylene by peroxyformic
`acid (45). The parallel reaction course and isotope effects for
`the chemical and enzymatic reactions strongly argue, in turn,
`that oxirenes are also not intermediates in the enzymatic
`oxidation of acetylenes. Oxirene intermediates would, if any(cid:173)
`thing, be destabilized by the interactions available within the
`cytochrome P-450 active site (e.g. metal coordination, hydro(cid:173)
`gen bonding) and would therefore be even less likely to
`accumulate prior to a rate-limiting step coupled to hydrogen
`migration.
`The strong analogy between the enzymatic and m-chloro(cid:173)
`perbenzoic acid reactions contrasts with the reaction of acet(cid:173)
`ylenes with hydroxyl radicals. Hydroxyl radicals readily add
`to terminal acetylenes, including acetylene, propargyl alcohol,
`and 3-hydroxy-3-methyl-l-butyne, but the corresponding
`acids are not obtained and products compatible with hydrogen
`migration are not observed (46). Products analogous to those
`obtained in the enzymatic reaction are not obtained even if
`Cu2+ or Fe+3 is added to the Fenton system. The Fenton
`oxidation of phenylacetylene differs in that it gives a trace of
`phenylacetic acid (Fig. 6), but is generally consistent with the
`earlier work in that phenylacetic acid is but a very minor
`component of a complex mixture of products. Clearly, the
`two-electron oxidation of acetylenes mediated by m-chloro(cid:173)
`perbenzoic acid, which exclusively yields the product obtained
`in the enzymatic reaction, better models cytochrome P-450
`catalysis than the corresponding reaction with hydroxyl rad(cid:173)
`icals.
`The sharp contrast between the large isotope effects on
`metabolite formation and the absence of a detectable isotope
`effect on cytochrome P-450 destruction requires the oxidative
`trajectories that result in metabolite formation and enzyme
`inactivation to diverge prior to the point where the hydrogen
`shifts in the former pathway. This conclusion specifically
`rules out destruction of the enzyme by the ketene or any other
`species subsequent to migration of the hydrogen. The differ(cid:173)
`ential isotope effects are consistent with the fact that the
`oxygen finishes on the terminal carbon in the metabolite and
`the internal carbon in the heme adduct (7, 24, 25).
`The oxidation of asymmetrically substituted acetylenes can,
`in principle, yield two a-ketocarbenes that are formally re(cid:173)
`lated to a common oxirene (Scheme 2) (32). If the a-ketocar(cid:173)
`benes are not interconvertible via the oxirene, one a-ketocar-
`
`bene isomer could give rise to the ketene metabolite and the
`other could alkylate the prosthetic heme. The a-ketocarbenes,
`however, can only be involved in the enzymatic reaction if a(cid:173)
`ketocarbene formation is followed by a rate-determining hy(cid:173)
`drogen shift in the pathway to metabolites. The required
`formation of a relatively stable carbene intermediate is feasi(cid:173)
`ble in view of the chemical synthesis of stable carbene-iron
`complexes (47-50) and of the fact that such structures have
`been postulated for the stable complexes formed in the reac(cid:173)
`tions of cytochrome P-450 with methylenedioxyphenyl com(cid:173)
`pounds and halocarbons (51-53). Carbene complexes are read(cid:173)
`ily detected in microsomal incubations because they have a
`characteristic absorption in the 440-490 nm range. We have
`recently demonstrated that fairly stable complexes with an
`absorption maximum at 445 nm are formed in the reactions
`of cytochrome P-450 with ethyl diazoacetate and diazoaceto(cid:173)
`phenone.4 The carbene from diazoacetophenone is identical
`to that expected if a carbene intermediate is generated by
`oxygen addition to the internal carbon of phenylacetylene.
`The microsomal oxidation of phenylacetylene, however, is not
`accompanied by the detectable formation of a species that
`absorbs in the 445 nm region. 5 The absence of such a chro(cid:173)
`mophore, in view of the fact that the chromophore is readily
`detected when the expected carbene is generated by an alter(cid:173)
`native procedure (from the diazoketone), makes the interven(cid:173)
`tion of a-ketocarbene intermediates unlikely.
`The mechanism for enzymatic carbon-carbon triple bond
`oxidation must adhere to the following constraints: (a) con(cid:173)
`current ketene formation and heme alkylation, (b) quantita(cid:173)
`tive shift of the acetylenic hydrogen in the ketene pathway,
`(c) large primary isotope effects on metabolite formation but
`not heme alkylation, (d) incorporation of one atom of molec(cid:173)
`ular oxygen into the metabolite, (e) location of the oxygen on
`the terminal carbon in metabolites but on the internal carbon
`in heme adducts, and (/) strong parallels in the reactions of
`acetylenes with cytochrome P-450 and peracids but not hy(cid:173)
`droxyl radicals. These results require heme alkylation and
`metabolite formation to diverge prior to (or during) transfer
`of the oxygen to the terminal carbon for metabolite formation
`and the internal carbon for heme alkylation. The preference
`for oxygen transfer to the terminal carbon is shown by the
`absence of products from oxygen addition to the internal
`carbon in the analogous oxidation by m-chloroperbenzoic
`acid. The substrate could, however, be bound a fraction of the
`time in an orientation that forces oxygen transfer to the
`internal carbon. The relatively loose binding of substrates by
`cytochrome P-450 required for the observation of high intra(cid:173)
`molecular isotope effects (41, 42) suggests that a more com(cid:173)
`plicated mechanism may be involved. One alternative is for
`enzymatic electron transfer from the 1r·bond to precede car(cid:173)
`bon-oxygen bond formation in the heme alkylation pathway
`(Scheme 3, upper mechanism). The partitioning of substrates
`between metabolism and heme alkylation would be deter(cid:173)
`mined by the ratio of electron transfer to direct oxygen
`addition. A second alternative is for the iron-oxo complex to
`add to the phenylacetylene 1r-bond to form the two possible
`metallooxocyclobutene isomers (Scheme 3, lower mechanism).
`Rearrangement of the isomer with the phenyl vicinal to the
`iron would result in ketene formation whereas internal ligand
`transfer in the isomer with the phenyl vicinal to the oxygen
`would result in heme alkylation. The isotope effect on metab(cid:173)
`olite formation requires, however, reversible formation of the
`Ar~
`H
`SCHEME 2. The theoretical relationship between the two carbenes
`and the oxirene that could result from oxidation of an arylacetylene.
`
`4 P.R. Ortiz de Montellano and E. A. Komives, unpublished results.
`6 A search for long wavelength absorption in incubations of phen(cid:173)
`ylacetylene with liver microsomes from phenobarbital-induced rats
`has been fruitless.
`
`Boehringer Ex. 2017
`Mylan v. Boehringer Ingelheim
`IPR2016-01564
`Page 4
`
`

`
`3334
`
`Mechanism of rr-Bond Oxidation
`
`N/N F.fL N/N . -N/N r N/ -
`
`•
`Ar--
`
`o-
`Ar -t..:
`~
`N-----N
`Felli/
`/
`N~N
`o, J
`p
`Aif
`
`[N/N 7\ N/Nl
`~ ~
`'==(
`'-H +
`
`N
`
`/
`/
`Fem
`N-----N
`+Ar..,
`C
`c== -=
`0
`w'
`
`14. Wade, A., Symons, A. M., Martin, L., and Parke, D. V. (1980)
`Biochem. J. 188, 867-872
`15. Wade, A., Symons, A.M., Martin, L., and Parke, D. V. (1979)
`Biochem. J. 184, 509-517
`16. Sullivan, H. R., Roffey, P., and McMahon, R. E. (1979) Drug
`Metab. Dispos. 7, 76-80
`17. Ortiz de Montellano, P. R., and Kunze, K. L. (1980) J. Am. Chem.
`Soc. 102, 7373-7375
`18. Ortiz de Montellano, P. R., and Kunze, K. L. (1981) Arch.
`Biochem. Biophys. 209, 710-712
`19. McMahon, R. E., Turner, J. C., Whitaker, G. W., and Sullivan,
`H. R. (1981) Biochem. Biophys. Res. Commun. 99,662-667
`20. El Masri, A.M., Smith, J. N., and Williams, R. T. (1958) Biochem.
`J. 68, 199-204
`21. White, I. N. H., and Muller-Eberhard, U. (1977) Biochem. J.
`166,57-64
`22. Ortiz de Montellano, P.R., Kunze, K. L., Yost, G. S., and Mico,
`B. A. (1979) Proc. Natl. Acad. Sci. U.S. A. 76, 746-749
`23. Ortiz de Montellano, P. R., and Kunze, K. L. (1980) J. Bioi.
`Chem. 255, 5578-5585
`24. Ortiz de Montellano, P.R., and Kunze, K. L. (1981) Biochemistry
`20, 7266-7271
`25. Ortiz de Montellano, P. R., Beilan, H. S., and Mathews, J. M.
`(1982)J. Med. Chem. 25,1174-1179
`26. Ortiz de Montellano, P. R., Mico, B. A., Mathews, J. M., Kunze,
`K. L., Miwa, G. T., and Lu, A. Y. H. (1981) Arch. Biochem.
`Biophys. 210,717-728
`27. Orton, T. C., and Parker, G. L. (1982) Drug Metab. Dispos. 10,
`110-115
`28. Gibson, G. G., Orton, T. C., and Tamburini, P. P. (1983) Biochem.
`J. 203, 161-168
`29. Alvares, A. P., and Kappas, A. (1977) J. Biol. Chem. 252, 6373-
`6378
`30. Thomas, P. E., Reik, L. M., Ryan, D. E., and Levin, W. (1981) J.
`Bioi. Chem. 256, 1044-1052
`31. Ogata, Y., Sawaki, Y., and Inoue, H. (1973) J. Org. Chem. 38,
`1044-1045
`32. Lewars, E. G. (1983) Chem. Rev. 83, 519-534
`33. More O'Ferrall, R. A. (1970) J. Chem. Soc. Sect. B 785-790
`34. Collins, C. J., Rainey, W. T., Smith, W. B., and Kaye, I. A. (1959)
`J. Am. Chem. Soc. 81,460-466
`35. Chiao, W.-B., and Saunders, W. H. (1978) J. Am. Chem. Soc.
`100, 2802-2805
`36. Simons, J. W., and Rabinovitch, B. S. {1963) J. Am. Chem. Soc.
`85, 1023-1024
`37. Goldstein, M. J., and Dolbier, W. R. (1965) J. Am. Chem. Soc.
`87, 2293-2295
`38. Kyba, E. P., and Hudson, C. W. (1977) J. Org. Chem. 42, 1935-
`1939
`39. Gillilan, R. E., Pohl, T. M., and Whalen, D. L. (1982) J. Am.
`Chem. Soc. 104, 4482-4484
`40. Halevi, E. A. (1963) Prog. Phys. Org. Chem. 1, 109-221
`41. Hjelmeland, L. M., Aronow, L., and Trudell, J. R. (1977) Biochem.
`Biophys. Res. Commun. 76, 541-549
`42. Groves, J. T., McClusky, G. A., White, R. E., and Coon, M. J.
`(1978) Biochem. Biophys. Res. Commun. 81, 154-160
`43. Torres, M .• Bourdelande, J. L., Clement, A., and Strausz, 0. P.
`(1983) J. Am. Chem. Soc. 105, 1698-1700
`44. Laganis, E. D., Janik, D. S., Curphey, T. J., and Lema!, D. M.
`(1983) J. Am. Chem. Soc. 105, 7457-7459
`45. Koller, J., and Plesnicar, B. (1982) J. Chem. Soc. Perkin Trans.
`II 1361-1365
`46. Walling, C., and El-Taliawi, G. (1973) J. Am. Chem. Soc. 95,
`848-850
`47. Mansuy, D., Lange, M., and Chottard, J. C. (1978) J. Am. Chem.
`Soc. 100, 3213-3214
`48. Mansuy, D., Guerin, P., and Chottard, J. C. (1979) J. Organomet.
`Chem. 171, 195-201
`49. Mansuy, D., Battioni, J.-P., Chottard, J.-C., and Ullrich, V. (1979}
`J. Am. Chem. Soc. 101,3971-3973
`50. Mansuy, D. (1980) Pure Appl. Chem. 52, 681-690
`51. Uehleke, H., Hellmer, K. M., and Tabarelli, 8. (1973) Xenobiotica
`3, 1-11
`52. Wolf, C. R., Mansuy, D., Nastainczyk, W., Deutschmann, G., and
`Ullrich, V. (1977) Mol. Pharmacol. 13, 698-705
`53. Elcombe, C. R., Bridges, J. W., Gray, T. J. B., Nimmo-Smith, R.
`
`t
`/¥·/r./=-/7
`
`N----N
`
`N-----N
`
`Nr----«
`
`O_#H
`
`o..
`
`O#Ar
`
`H
`A r - -
`Ar
`SCHEME 3. Two mechanisms for triple bond oxidation consistent
`with the available information. In the upper half of the scheme is a
`mechanism in which heme alkylation results from initial electron
`transfer and metabolite formation from direct oxygen transfer. In the
`bottom half is a mechanism involving the reversible formation of
`isomeric metallooxocyclobutenes.
`
`metallooxocyclobutene isomers followed by rate-determining
`hydrogen migration in the pathway to metabolites. Metal(cid:173)
`looxocyclobutane intermediates, first proposed by Sharpless
`et al. (54) tQ explain the oxidation of olefins by chromyl
`chloride, have been observed by NMR in the reaction of
`osmium tetroxide with 1,1-diphenylethylene (55) and have
`been invoked by Collman et al. (56) to explain olefin oxidation
`by an oxo-manganese complex. No precedent is yet available,
`however, for the formation of metallooxocyclobutene inter(cid:173)
`mediates with iron porphyrins

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket